Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation
Experimental Eye Research · 2026
DOI: 10.1016/j.exer.2026.111168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2026. Verfasst von Md Matiur Rahman Sarker und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA. Hauptthemen laut MEDLINE: Lipopolysaccharides, Endothelium, Corneal, Growth Hormone-Releasing Hormone, Sermorelin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Edward Via College of Osteopathic Medicine.
Abstract (Originalsprache)
The corneal endothelium preserves corneal transparency by regulating water movement between the anterior chamber and the stroma. Pathological conditions may lead to progressive corneal edema due to impairment of the endothelial pump-barrier function. In this study, we investigated the effects of JV-1-36, which is a growth hormone - releasing hormone antagonist (GHRHAnt), in an in vitro model of lipopolysaccharides (LPS)-induced corneal endothelial injury. Our findings suggest that JV-1-36 alleviates the effects of LPS in endothelial corneal cells, suppresses endothelial hyperpermeability and reactive oxygen species (ROS) generation, mitigates MAPK and STAT activation, and reduces pro-inflammatory cytokine production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA.
- School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA. Electronic address: barabutis@ulm.edu.
Förderung
- Edward Via College of Osteopathic Medicine
Zitieren
APA
Sarker, M. M. R., Fakir, S., Sigdel, M., Jackson, K., & Barabutis, N. (2026). Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation. Experimental Eye Research. https://doi.org/10.1016/j.exer.2026.111168
Vancouver
Sarker MMR, Fakir S, Sigdel M, Jackson K, Barabutis N. Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation. Experimental Eye Research. 2026. doi:10.1016/j.exer.2026.111168
BibTeX
@article{Sarker2026,
author = {Sarker, Md Matiur Rahman and Fakir, Saikat and Sigdel, Madan and Jackson, Keith and Barabutis, Nektarios},
title = {Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation},
journal = {Experimental Eye Research},
year = {2026},
doi = {10.1016/j.exer.2026.111168}
}
EUVIMED